The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.


Updates from The Motley Fool

Latest updates on AstraZeneca from Fool.com.  The Fool has written over 600 articles on AstraZeneca.
Is Agenus Inc. (AGEN) a Buy?

This cancer-focused biotech will take plenty of shots on goal in the years ahead.

3 High-Yield International Stocks

Are you looking for income and willing to invest outside the U.S.? Here's why you should consider...



Stock Performance

View Interactive AZN Charts
Sponsored by

Key Data Points

Primary metrics and data points about AstraZeneca.
Current Price: $37.68
Prev Close: $37.72
Open: $37.46
Bid: $36.00
Ask: $39.00
Day's Range: $37.43 - $37.77
52wk Range: $31.99 - $39.76
Volume: 1,705,160
Avg Vol 4,063,669
Market Cap: $95B
P/E (ttm): 16.91
EPS (ttm): $0.00
Div & Yield: $0.90 (3.6%)

Company Rating

What our community thinks about AstraZeneca.
CAPS Rating 4 out of 5
 
708 Outperform
44 Underperform
CAPS All Stars
 
148 Outperform
8 Underperform

How do you think AstraZeneca will perform against the market?



You pick for AstraZeneca is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Pascal Soriot, CEO

90% Approve

Based on 682 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AstraZeneca.

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers